SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-18-000008
Filing Date
2018-08-07
Accepted
2018-08-07 17:28:21
Documents
70
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q egrx_q2x2018.htm 10-Q 1020887
2 EXHIBIT 31.1 exhibit311q22018.htm EX-31.1 9698
3 EXHIBIT 31.2 exhibit312q22018.htm EX-31.2 9661
4 EXHIBIT 32.1 exhibit321q22018.htm EX-32.1 10012
  Complete submission text file 0000827871-18-000008.txt   5946212

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT egrx-20180630.xml EX-101.INS 1177951
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20180630.xsd EX-101.SCH 42026
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20180630_cal.xml EX-101.CAL 99141
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20180630_def.xml EX-101.DEF 233035
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20180630_lab.xml EX-101.LAB 579404
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20180630_pre.xml EX-101.PRE 382889
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 18999198
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences